(function(doc, html, url) { var widget = doc.createElement("div"); widget.innerHTML = html; var script = doc.currentScript; // e = a.currentScript; if (!script) { var scripts = doc.scripts; for (var i = 0; i < scripts.length; ++i) { script = scripts[i]; if (script.src && script.src.indexOf(url) != -1) break; } } script.parentElement.replaceChild(widget, script); }(document, '

Opioid Use Disorder and Dementia Risk in the U.S.

What is it about?

Our study delves into the relationship between opioid use disorder (OUD) and the risk of Alzheimer's disease and other forms of dementia. By analyzing health records over two decades, we discovered that individuals with OUD are significantly more likely to develop dementia, with risks increasing over time. Notably, younger individuals under 65 with OUD show a higher likelihood of developing these cognitive conditions compared to their older counterparts. These findings underscore the need for early cognitive health screenings in younger populations with OUD, aiming for timely intervention and support.

Why is it important?

Our study is the first of its kind to illuminate the heightened risk of Alzheimer's and dementia in younger adults with opioid use disorder—a group traditionally overlooked in dementia research. This groundbreaking discovery not only challenges existing beliefs about the age-related nature of cognitive decline but also opens new avenues for early detection and intervention strategies. As the opioid crisis continues to intersect with an aging population, our findings provide timely evidence that could transform healthcare policies and improve the lives of millions at risk.

Read more on Kudos…
The following have contributed to this page:
Fares Qeadan
' ,"url"));